- Home
- INM vs SKYH Comparison
INM vs SKYH Comparison
Compare INM & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- SKYH
- Stock Information
- Founded
- INM 1981
- SKYH 2017
- Country
- INM Canada
- SKYH United States
- Employees
- INM N/A
- SKYH N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- SKYH Military/Government/Technical
- Sector
- INM Health Care
- SKYH Industrials
- Exchange
- INM Nasdaq
- SKYH Nasdaq
- Market Cap
- INM 5.0M
- SKYH 341.8M
- IPO Year
- INM N/A
- SKYH N/A
- Fundamental
- Price
- INM $2.11
- SKYH $10.13
- Analyst Decision
- INM
- SKYH Strong Buy
- Analyst Count
- INM 0
- SKYH 2
- Target Price
- INM N/A
- SKYH $14.25
- AVG Volume (30 Days)
- INM 120.8K
- SKYH 114.7K
- Earning Date
- INM 11-13-2025
- SKYH 11-11-2025
- Dividend Yield
- INM N/A
- SKYH N/A
- EPS Growth
- INM N/A
- SKYH N/A
- EPS
- INM N/A
- SKYH N/A
- Revenue
- INM $4,942,633.00
- SKYH $20,919,000.00
- Revenue This Year
- INM N/A
- SKYH $118.09
- Revenue Next Year
- INM N/A
- SKYH $88.34
- P/E Ratio
- INM N/A
- SKYH N/A
- Revenue Growth
- INM 7.50
- SKYH 94.38
- 52 Week Low
- INM $1.72
- SKYH $9.28
- 52 Week High
- INM $8.27
- SKYH $14.52
- Technical
- Relative Strength Index (RSI)
- INM 45.52
- SKYH 49.85
- Support Level
- INM $2.04
- SKYH $9.71
- Resistance Level
- INM $2.26
- SKYH $10.96
- Average True Range (ATR)
- INM 0.13
- SKYH 0.40
- MACD
- INM -0.01
- SKYH 0.00
- Stochastic Oscillator
- INM 21.74
- SKYH 42.41
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.